Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reduced serotonin vascular sensitivity in ergotamine abusers.

A Panconesi1, G Franchi, P L Del Bianco

  • 1Institute of Internal Medicine, University of Florence, Italy.

Cephalalgia : an International Journal of Headache
|December 1, 1989
PubMed
Summary

Ergotamine abusers exhibit decreased 5-hydroxytryptamine (5-HT) venous sensitivity. This reduced responsiveness may explain chronic headaches in abusers and withdrawal symptoms, suggesting 5-HT antagonism isn't key to ergotamine's migraine treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First Report of Diplodia Canker of Cypress Caused by Diplodia pinea f. sp. cupressi on Mediterranean Cypress in Tunisia.

Plant disease·2019
Same author

Alcohol as a dietary trigger of primary headaches: what triggering site could be compatible?

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2012
Same author

Triptans: low utilization and high turnover in the general population.

Cephalalgia : an international journal of headache·2009
Same author

Patterns of triptans use: a study based on the records of a community pharmaceutical department.

Cephalalgia : an international journal of headache·2007
Same author

[On post-traumatic ptosis].

Revue de stomatologie et de chirurgie maxillo-faciale·2003
Same author

Susceptibility of cypress seedlings to the eriophyoid mite Trisetacus juniperinus.

Experimental & applied acarology·2003

Area of Science:

  • Pharmacology
  • Neuroscience
  • Vascular Biology

Background:

  • Ergotamine is a medication used for migraine treatment.
  • The mechanism of ergotamine's action, particularly its effect on 5-hydroxytryptamine (5-HT) receptors, is not fully understood.
  • Understanding ergotamine's interaction with 5-HT is crucial for both therapeutic efficacy and potential side effects like chronic headache in abusers.

Purpose of the Study:

  • To investigate the effect of ergotamine on 5-hydroxytryptamine (5-HT) venous sensitivity in migraine patients.
  • To compare 5-HT venous sensitivity in ergotamine abusers versus non-abusers.
  • To determine if 5-HT antagonism contributes to the therapeutic effect of ergotamine in migraine.

Main Methods:

  • Studied venous sensitivity to 5-HT in hand veins of ergotamine abusers and non-abusers.

Related Experiment Videos

  • Measured venous contraction in response to 5-HT before and after ergotamine withdrawal in abusers.
  • Administered ergotamine intramuscularly and locally to veins in non-users to assess acute effects on 5-HT venoconstriction.

    • Main Results:

    • Ergotamine abusers showed significantly reduced 5-HT-induced hand vein contraction during abuse compared to seven days post-withdrawal.
    • In non-ergotamine users, acute intramuscular or local ergotamine administration did not significantly alter 5-HT venoconstriction.
    • The study indicates that 5-HT antagonism is unlikely to be the primary mechanism for ergotamine's migraine treatment.

    Conclusions:

    • Reduced 5-HT responsiveness during ergotamine abuse may contribute to chronic headaches in abusers and withdrawal symptoms.
    • The findings suggest that ergotamine's therapeutic effect during a migraine attack is not mediated by 5-HT antagonism.
    • This research provides insights into the complex relationship between ergotamine, 5-HT pathways, and headache disorders.